Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4178561000168112 | risankizumab (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4178571000168118 | risankizumab | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| risankizumab | Is a | medicinal product | true | Inferred relationship | Some | ||
| risankizumab | has intended active ingredient | risankizumab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| risankizumab 75 mg/0.83 mL injection, syringe | Is a | True | risankizumab | Inferred relationship | Some | |
| risankizumab 150 mg/mL injection, pen device | Is a | True | risankizumab | Inferred relationship | Some | |
| risankizumab 150 mg/mL injection, syringe | Is a | True | risankizumab | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR